Methods of diagnosing liver fibrosis

The present invention provides a method of diagnosing the presence or severity of liver fibrosis in an individual by detecting alpha2-macroglobulin (alpha2-MG) in sample from the individual; detecting hyaluronic acid (HA) in a sample from the individual; detecting tissue inhibitor of a metalloprotei...

Full description

Saved in:
Bibliographic Details
Main Authors OH ESTHER H, WALSH MICHAEL J, ROSE STEVEN L
Format Patent
LanguageEnglish
Published 20.04.2006
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PHYSICS
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
TESTING
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a method of diagnosing the presence or severity of liver fibrosis in an individual by detecting alpha2-macroglobulin (alpha2-MG) in sample from the individual; detecting hyaluronic acid (HA) in a sample from the individual; detecting tissue inhibitor of a metalloproteinases-1 (TIMP-1) in a sample from the individual; and diagnosing the presence or severity of liver fibrosis in the individual based on the presence or level of alpha-MG, HA and TIMP-1.
Bibliography:Application Number: US20050504544